Psyched Wellness Included in First Psychedelic Exchange Traded Fund

Toronto, Ontario, January 26, 2021 – Psyched Wellness Ltd. (CSE:PSYC, OTCQB:PSYCF, FRANKFURT:5U9) (the “Company” or “Psyched”) a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is one of the 17 companies in the United States and Canada that will be included in the first psychedelic exchange-traded fund, which is managed by Horizons ETF Management.

The Horizons Psychedelic Stock Index ETF index is expected to start trading on Tuesday, Jan. 26, 2021, under the ticker PSYK on the NEO Exchange.

"We are pleased to be included in the first psychedelics ETF and to be recognized as one of the leading companies in the field of psychedelic health and wellness and pharmaceuticals," said Jeff Stevens, chief executive officer of Psyched. "We are the only publicly traded company working with a legal psychoactive mushroom and we are advancing novel muscimol-based therapeutics using our proprietary extract, AME-1."